SEARCH

SEARCH BY CITATION

References

  • Aarestrup, F. M., F. Bager, M. Madsen, N. E. Jensen, A. Meyling & H. C. Wegener: Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. APMIS 1998, 106, 606622.
  • Aarestrup, F. M. & H. C. Wegener: The effects of antibiotic usage in food animals on the development of antimicrobial resistance of importance for humans in Campylobacter and Escherichia coli. Microb. Infect. 1999, 1, 63944.DOI: 10.1016/S1286-4579(99)80064-1
  • Aarestrup, F. M.: Occurrence, selection and spread of resistance to antimicrobial agents used for growth promotion for food animals in Denmark. PMIS 2000a, 101 (Suppl.), 148.
  • Aarestrup, F. M.: Characterization of glycopeptide resistant Enterococcus faecium from broilers and pigs in Denmark. Genetic evidences that the persistence of GRE among the pig population is associated with co-selection by resistance to macrolides. J. Clin. Microbiol. 2000b, 38, 27742777.
  • Aarestrup, F. M., A. M. Seyfarth, H. D. Emborg, K. Pedersen, R. S. Hendriksen & F. Bager: Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob. Agents Chemother. 2001, 45, 20542059.DOI: 10.1128/AAC.45.7.2054-2059.2001
  • Acha, P. N. & B. Szyfres: Zoonoses and communicable diseases common to man and animals. 2nd ed. Pan American Health Organisation, Pan American Sanitary Bureau, regional office of the World Health Organization, Washington D. C., USA, 1994.
  • Adak, G. K., S. M. Long & S. J. O'Brien: Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut 2002, 51, 832841.DOI: 10.1136/gut.51.6.832
  • Aliabadi, F. S. & P. Lees: Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation. Int. J. Antimicrob. Agents 2000, 14, 307313.DOI: 10.1016/S0924-8579(00)00142-4
  • Anderson, A. D., J. M. Nelson, S. Rossiter & F. J. Angulo: Public health consequences of use of antimicrobial agents in food animals in the United States. Microb. Drug Resist. 2003, 9, 373379.DOI: 10.1089/107662903322762815
  • Andes, D.: Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections. Curr. Opin. Infect. Dis. 2001, 14, 165172.DOI: 10.1097/00001432-200104000-00010
  • Ashbolt, R., R. Givney, J. E. Gregory, G. Hall, R. Hundy, M. Kirk, I. McKay, L. Meuleners, G. Millard, J. Raupach, P. Roche, N. Prasopa-Plaizier, M. K. Sama, R. Stafford, N. Tomaska, L. Unicomb, C. Williams: OzFoodNet Working Group: Enhancing foodborne disease surveillance across Australia in 2001: the OzFoodNet Working Group. Commun. Dis. Intell. 2002, 26, 375406.
  • Barza, M. & K. Travers: Excess infections due to antimicrobial resistance: the “Attributable Fraction”. Clin. Infect. Dis. 2002, 34, 126130.
  • Black, W. D.: The use of antimicrobial drugs in agriculture. Can. J. Physiol. Pharmacol. 1984, 62, 10441048.
  • Boerlin, P., A. Wissing, F. M. Aarestrup, J. Frey & J. Nicolet: Antimicrobial growth promoter ban and resistance to macrolides and vancomycin in enterococci from pigs. J. Clin. Microbiol. 2001, 39, 41934195.
  • Borgen, K., M. Sørum, H. Kruse & Y. Wasteson: Persistence of vancomycin-resistant enterococci (VRE) on Norwegian broiler farms. FEMS Microbiol. Lett. 2000, 191, 255258.
  • Bouza, E., R. San Juan, P. Munoz, A. Voss & J. Kluytmans: Co-operative Group of the European Study Group on Nosocomial Infections: A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin. Microbiol. Infect. 2001, 7, 523531.
  • Burgess, D. S.: Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance. Chest 1999, 115, 1923.
  • Chambers, H. F.: The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 2001, 7, 178182.
  • Chiu, C. H., T. L. Wu, L. H. Su, C. Chu, J. H. Chia, A. J. Kuo, M. S. Chien & T. Y. Lin: The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. New Engl. J. Med. 2002, 346, 413419.
  • Coyle, E. F., S. R. Palmer, C. D. Ribeiro, H. I. Jones, A. J. Howard, L. Ward & B. Rowe: Salmonella enteritidis phage type 4 infection: association with hen's eggs. Lancet 1988, 2, 12951297.
  • Craig, W. A.: Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 1998, 26, 110.
  • DANMAP: DANMAP – 2003: Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans. ISSN 1600–2032, 2004.
  • Del Grosso, M., A. Caprioli, P. Chinzari, M. C. Fontana, G. Pezzotti, A. Manfrin, E. D. Giannatale, E. Goffredo & A. Pantosti: Detection and characterization of vancomycin-resistant enterococci in farm animals and raw meat products in Italy. Microb. Drug Resist. 2000, 6, 313318.
  • Diekema, D. J., M. A. Pfaller, R. N. Jones, G. V. Doern, K. C. Kugler, M. L. Beach & H. S. Sader: Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. Int. J. Antimicrob. Agents 2000, 13, 257271.
  • Eady, E. A. & J. H. Cove: Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus– an emerging problem for the management of skin and soft tissue infections. Curr. Opin. Infect. Dis. 2003, 16, 103124.
  • EMEA: Antibiotic resistance in the European Union associated with therapeutic use of veterinary medicines. Report and qualitative risk assessment by the Committee for Veterinary Medical Products, The European Agency for the evaluation of Medical products, 14 July 1999.
  • Endtz, H. P., G. J. Ruijs, B. Van Klingeren, W. H. Jansen, T. Van Der Reyden & R. P. Mouton: Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J. Antimicrob. Chemother. 1991, 27, 199208.
  • Engberg, J., F. M. Aarestrup, P. G. Smidt, I. Nachamkin & D. E. Taylor: Quinolone and macrolide resistance in Campylobacter jejuni and coli: A review of mechanisms and trends over time of resistance profiles in human isolates. Emerg. Infect. Dis. 2001, 7, 2434.
  • Engberg, J., J. Neimann, E. M. Nielsen, F. M. Aarestrup & V. Fussing: Quinolone resistant campylobacter infections in Denmark: risk factors and clinical consequences. Emerg. Infect. Dis. 2004, 10, 10561063.
  • Fluit, A. C., J. Verhoef & F. J. Schmitz; European SENTRY Participants: Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997–1998. Eur. J. Clin. Microbiol. Infect. Dis. 2001, 20, 617625.
  • Gales, A. C., H. S. Sader & R. N. Jones: Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997–2000). Diagn. Microbiol. Infect. Dis. 2002, 44, 301311.
  • Garau, J., M. Xercavins, M. Rodriguez-Carballeira, J R. Gomez-Vera, I. Coll, D. Vidal, T. Llovet & A. Ruiz-Bremon: Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob. Agents Chemother. 1999, 43, 27362741.
  • Gaudreau, C. & H. Gilbert: Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montreal, Canada. Antimicrob. Agents Chemother. 2003, 47, 20272029.
  • Gordon, K. A. & R. N. Jones; SENTRY Participant Groups (Europe, Latin America, North America): Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn. Microbiol. Infect. Dis. 2003, 45, 295301.
  • Guerri Santos, M. L. & R. Rotger: Change in resistance to quinolones and betalactams in different serogroups of Salmonella during the last decade in a Madrid hospital. Rev. Esp. Quimioter. 2004, 17, 3743.
  • Hein, I., C. Schneck, M. Knogler, G. Feierl, P. Plesss, J. Kofer, R. Achmann & M. Wagner: Campylobacter jejuni isolated from poultry and humans in Styria, Austria: epidemiology and ciprofloxacin resistance. Epidemiol. Infect. 2003, 130, 377386.
  • Helms, M., P. Vastrup, P. Gerner-Smidt & K. Mølbak: Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg. Infect. Dis. 2002, 8, 490495.
  • Heuer, O. E., K. Pedersen, J. S. Andersen & M. Madsen: Vancomycin-resistant enterococci (VRE) in broiler flocks 5 years after the avoparcin ban. Microb. Drug Resist. 2002, 8, 133138.
  • Heurtin-Le Corre, C., P. Y. Donnio, M. Perrin, M. F. Travert & J. L. Avril: Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype typhimurium isolates from humans and animals. J. Clin. Microbiol. 1999, 37, 266269.
  • Hoban, D. J., D. J. Biedenbach, A. H. Mutnick & R. N. Jones: Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn. Microbiol. Infect. Dis. 2003, 45, 279285.
  • Holmberg, S. D., S. L. Solomon & P. A. Blake: Health and economic impacts of antimicrobial resistance. Rev. Infect. Dis. 1987, 9, 10651078.
  • Hsueh, P. R., L. J. Teng, S. P. Tseng, C. F. Chang, J. H. Wan, J. J. Yan, C. M. Lee, Y. C. Chuang, W. K. Huang, D. Yang, J. M. Shyr, K. W. Yu, L. S. Wang, J. J. Lu, W. C. Ko, J. J. Wu, F. Y. Chang, Y. C. Yang, Y. J. Lau, Y. C. Liu, C. Y. Liu, S. W. Ho & K. T. Luh: Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg. Infect. Dis. 2004, 10, 6068.
  • Humphrey, T. J.: Public-health aspects of Salmonella infections. In: Salmonella in domestic animals. Eds.: C.Wray & A.Wray. CABI publishing, CAB International, Wallingford, United Kingdom, 2000.
  • Jensen, V. F., E. Jacobsen & F. Bager: Veterinary antimicrobial-usage statistics based on standardized measures of dosage. Prev. Vet. Med. 2004, 64, 201215.
  • Jiang, Z. D., B. Lowe, M. P. Verenkar, D. Ashley, R. Steffen, N. Tornieporth, F. Von Sonnenburg, P. Waiyaki & H. L. DuPont: Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J. Infect. Dis. 2002, 185, 497502.
  • Jones, M. E., F. J. Schmitz, A. C. Fluit, J. Acar, R. Gupta & J. Verhoef: Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group. Eur. J. Clin. Microbiol. Infect. Dis. 1999, 18, 403408.
  • Kaszanyitzky, E. J., Z. Egyed, S. Janosi, J. Keseru, Z. Gal, I. Szabo, Z. Veres & P. Somogyi: Staphylococci isolated from animals and food with phenotypically reduced susceptibility to beta-lactamase-resistant beta-lactam antibiotics. Acta Vet. Hung. 2004, 52, 717.
  • Klare, I., D. Badstubner, C. Konstabel, G. Bohme, H. Claus & W. Witte: Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb. Drug Resist. 1999, 5, 4552.
  • Lee, J. H.: Methicillin (oxacillin)-resistant Staphylococcus aureus strains isolated from major food animals and their potential transmission to humans. Appl. Environ. Microbiol. 2003, 69, 64896494.
  • Lee, L. A., N. D. Puhr, E. K. Maloney, N. H. Bean & R. V. Tauxe: Increase in antimicrobial-resistant Salmonella infections in the United States, 1989–1990. J. Infect. Dis. 1994, 170, 128134.
  • Lees, P. & F. S. Aliabadi: Rational dosing of antimicrobial drugs: animals versus humans. Int. J. Antimicrob. Agents 2002, 19, 269284.
  • Levy, S. B.: Microbial resistance to antibiotics. An evolving and persistent problem. Lancet 1982, 10, 8388.
  • Lucey, B., B. Cryan, F. O'Halloran, P. G. Wall, T. Buckley & S. Fanning: Trends in antimicrobial susceptibility among isolates of Campylobacter species in Ireland and the emergence of resistance to ciprofloxacin. Vet. Rec. 2002, 151, 317320.
  • Malorny, B., A. Schroeter, B. Guerra & R. Helmuth: Incidence of quinolone resistance in strains of Salmonella isolated from poultry, cattle and pigs in Germany between 1998 and 2001. Vet. Rec. 2003, 153, 643648.
  • Manson, J. M., J. M. Smith & G. M. Cook: Persistence of vancomycin-resistant enterococci in New Zealand broilers after discontinuation of avoparcin use. Appl. Environ. Microbiol. 2004, 70, 57645768.
  • Marimon, J. M., M. Gomariz, C. Zigorraga, G. Cilla & E. Perez-Trallero: Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003. Antimicrob. Agents Chemother. 2004, 48, 37893793.
  • Martin, L. J., M. Fyfe, K. Dore, J. A. Buxton, F. Pollari, B. Henry, D. Middleton, R. Ahmed, F. Jamieson, B. Ciebin, S. A. McEwen & J. B. Wilson: Multi-Provincial Salmonella Typhimurium Case-Control Study Steering Committee: Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. J. Infect. Dis. 2004, 189, 377384.
  • Meng, J. & M. P. Doyle: Emerging issues in microbiological food safety. Annu. Rev. Nutr. 1997, 17, 25575.
  • Nachamkin, I., H. Ung & M. Li: Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982–2001. Emerg. Infect. Dis. 2002, 8, 15011503.
  • Oyofo, B. A., M. Lesmana, D. Subekti, P. Tjaniadi, W. Larasati, M. Putri, C. H. Simanjuntak, N. H. Punjabi, W. Santoso, Muzahar, Sukarma, Sriwati, S. Sarumpaet, M. Abdi, R. Tjindi, H. Ma'ani, A. Sumardiati, H. Handayani, J. R. Campbell, W. K. Alexander, H. J. 3rd Beecham & A. L. Corwin: Surveillance of bacterial pathogens of diarrhea disease in Indonesia. Diagn. Microbiol. Infect. Dis. 2002, 44, 227234.
  • Pedersen, K. B., F. M. Aarestrup, N. E. Jensen, F. Bager, L. B. Jensen, S. E. Jorsal, T. K. Nielsen, H. C. Hansen, A. Meyling & H. C. Wegener: The need for a veterinary antibiotic policy. Vet. Rec. 1999, 144, 5053.
  • Poupard, J., J. Brown, R. Gagnon, M. J. Stanhope & C. Stewart: Methods for data mining from large multinational surveillance studies. Antimicrob. Agents Chemother. 2002, 46, 24092419.
  • Rennie, R. P., R. N. Jones & A. H. Mutnick; SENTRY Program Study Group (North America): Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn. Microbiol. Infect. Dis. 2003, 45, 287293.
  • Sader, H. S., R. N. Jones & J. B. Silva; SENTRY Participants Group (Latin America): Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns. Diagn. Microbiol. Infect. Dis. 2002a, 44, 281288.
  • Sader, H. S., R. N. Jones, S. Andrade-Baiocchi & D. J. Biedenbach; SENTRY Participants Group (Latin America): Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn. Microbiol. Infect. Dis. 2002b, 44, 273280.
  • Smith, K. E., J. M. Besser, C. W. Hedberg, F. T. Leano, J. B. Bender, J. H. Wicklund, B. P. Johnson, K. A. Moore & M. T. Osterholm: Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992–1998. Investigation Team. New Engl. J. Med. 1999, 340, 15251532.
  • Su, L. H., C. H. Chiu, A. J. Kuo, J. H. Chia, C. F. Sun, H. S. Leu & T. L. Wu: Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983–1999. Epidemiol. Infect. 2001, 127, 207213.
  • Swann, M. M.: Joint committee on the use of antibiotics in animal husbandry and veterinary medicine. H.M.S.O., London, 1969.
  • Thomas, J. K., A. Forrest, S. M. Bhavnani, J. M. Hyatt, A. Cheng, C. H. Ballow & J. J. Schentag: Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob. Agents Chemother. 1998, 42, 521527.
  • Threlfall, E. J., L. R. Ward, J. A. Skinner & B. Rowe: Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and wales: a comparison of data for 1994 and 1996. Microb. Drug Resist. 1997, 3, 263266.
  • Tollefson, L., F. J. Angulo & P. J. Fedorka-Cray: National surveillance for antibiotic resistance in zoonotic enteric pathogens. Vet. Clin. North Am. Food Anim. Pract. 1998, 14, 141150.
  • Toutain, P. L., J. R. Del Castillo & A. Bousquet-Melou: The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Res. Vet. Sci. 2002, 73, 105114.
  • Turnidge, J., J. Bell, D. J. Biedenbach & R. N. Jones: Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998–1999. Int. J. Antimicrob. Agents 2002, 20, 1017.
  • Van Den Bogaard, A. E., N. Bruinsma & E. E. Stobberingh: The effect of banning avoparcin on VRE carriage in The Netherlands. J. Antimicrob. Chemother. 2000, 46, 146148.
  • Van Leeuwen, W. J., J. Van Embden, P. A. Guinee, E. H. Kampelmacher, A. Manten, M. Van Schothorst & C. E. Voogd: Reduction of the number of tetracycline-resistant strains of Salmonella in the Netherlands. Tijdschr. Diergeneeskd. 1979, 104, 923927.
  • Witte, W.: Medical consequences of antibiotic use in agriculture. Science 1998, 279, 996997.
  • Wiuff, C., J. Lykkesfeldt, O. Svendsen & F. M. Aarestrup: The effects of oral and intramuscular administration and dose escalation of enrofloxacin on the selection of quinolone resistance among Salmonella and coliforms in pigs. Res. Vet. Sci. 2003, 75, 185193.
  • World Health Organization: WHO global principles for the containment of antimicrobial resistance in animals intended for food. Report of a WHO consultation, 5–9 June, Geneva, Switzerland, 2000.
  • Wray, C. & J. C. Gnanou: Antibiotic resistance monitoring in bacteria of animal origin: analysis of national monitoring programmes. Int. J. Antimicrob. Agents 2000, 14, 291294.